Published by
@ShahidNShah
@ShahidNShah
Lumee™ Oxygen Platform is CE Marked for use in the European Union and all countries that accept the CE Mark. Caution: Investigational Device Limited by Federal (or the United States) Law to Investigational Use.
Profusas first clinical offering, the Lumee™ Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. Potential applications include monitoring of compromised tissue, such as peripheral artery disease.
In the European Union, the Lumee™ Oxygen Platform may help salvage limbs by providing the medical practitioner with a new way to continuously measure tissue oxygen levels in the ischemic limb before, during, and after treatment, enabling appropriate therapy to be administered in a timely fashion before advanced symptoms appear.
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Dec 20, 2024 at 12:59pm